Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EW | -0.02% | $46.22B | -15.13% | 0.00% |
MQ | -0.04% | $2.80B | +10.54% | 0.00% |
AXON | 0.04% | $57.06B | +151.75% | 0.00% |
KRNY | -0.04% | $431.39M | +4.38% | 6.67% |
VTLE | -0.05% | $709.07M | -59.25% | 0.00% |
DAKT | 0.11% | $807.42M | +17.68% | 0.00% |
UPWK | -0.13% | $1.76B | +19.95% | 0.00% |
PRA | -0.18% | $1.22B | +106.78% | 0.00% |
GTLS | -0.20% | $7.64B | +12.20% | 0.00% |
SXC | -0.20% | $728.85M | -15.09% | 5.60% |
DDOG | 0.22% | $47.48B | +8.10% | 0.00% |
GEV | -0.24% | $147.21B | +205.24% | 0.05% |
GATX | -0.27% | $5.71B | +12.25% | 1.49% |
PARR | -0.28% | $1.79B | +44.35% | 0.00% |
WTTR | -0.30% | $1.01B | -7.77% | 2.83% |
WNC | -0.31% | $467.69M | -48.69% | 2.92% |
MOD | 0.32% | $4.85B | -14.60% | 0.00% |
RCL | -0.33% | $92.70B | +109.19% | 0.72% |
HAFC | -0.34% | $787.03M | +50.06% | 4.01% |
TDUP | 0.35% | $807.63M | +285.88% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GSK | 52.70% | $80.01B | +1.75% | 4.17% |
NVS | 47.76% | $234.79B | +11.97% | 3.25% |
HLN | 47.02% | $45.41B | +14.89% | 1.77% |
AZN | 46.61% | $222.71B | -7.86% | 2.18% |
BIIB | 45.46% | $19.83B | -42.85% | 0.00% |
PFE | 45.41% | $146.57B | -10.05% | 6.62% |
REGN | 45.34% | $60.43B | -48.18% | 0.16% |
JNJ | 42.88% | $379.41B | +5.34% | 3.20% |
SNN | 42.28% | $13.59B | +9.79% | 2.47% |
ALC | 42.17% | $43.87B | -2.03% | 0.38% |
GMAB | 42.12% | $13.45B | -16.69% | 0.00% |
UL | 41.86% | $150.82B | +8.55% | 3.19% |
TMO | 41.61% | $162.60B | -20.63% | 0.38% |
COO | 41.07% | $15.30B | -13.41% | 0.00% |
ING | 40.60% | $70.12B | +28.24% | 5.20% |
GILD | 40.35% | $142.48B | +63.70% | 2.75% |
VOD | 39.95% | $26.61B | +18.72% | 4.50% |
MDT | 39.89% | $114.54B | +14.51% | 3.08% |
KHC | 39.83% | $31.33B | -17.74% | 6.12% |
DHR | 39.52% | $147.08B | -16.55% | 0.57% |
SeekingAlpha
Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN stock is upgraded to buy.
Yahoo
The biotech is taking inspiration from cystic fibrosis treatment and applying a similar approach to developing "corrector" and "potentiator" medicines for the kidney disease.
Yahoo
Kymera Therapeutics, Inc. (NASDAQ:KYMR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley analyst Judah Frommer assumed coverage of the company’s stock with an “Overweight” rating and a price objective of $70, down from $79. The research firm mentioned that the company is developing oral small-molecule approaches to […]
Yahoo
With artificial intelligence (AI) fast becoming an ubiquitous part of everyday life, its further application in clinical trials holds considerable promise.
Yahoo
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of €2,452,461,656Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regis
SeekingAlpha
ClearBridge International Value Strategy outperformed its benchmark in Q2, boosted by strong stock selection within the industrials and financial sectors.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RRGB | -13.76% | $106.59M | -0.66% | 0.00% |
MXL | -12.77% | $1.31B | -32.00% | 0.00% |
AMPY | -11.15% | $136.34M | -52.59% | 0.00% |
HUSA | -9.16% | $20.99M | -8.33% | 0.00% |
XGN | -8.99% | $153.02M | +261.76% | 0.00% |
ORN | -8.98% | $342.14M | -1.37% | 0.00% |
EVGO | -8.47% | $464.22M | +2.67% | 0.00% |
TGI | -8.11% | $2.01B | +59.69% | 0.00% |
GALT | -7.87% | $155.06M | +3.81% | 0.00% |
DFDV | -7.64% | $363.21M | +2,422.23% | 0.00% |
FIX | -7.30% | $18.83B | +67.29% | 0.28% |
RDNT | -6.50% | $4.31B | -3.91% | 0.00% |
GEO | -6.32% | $3.69B | +67.82% | 0.00% |
EME | -6.21% | $24.51B | +45.85% | 0.18% |
EAT | -6.15% | $7.41B | +155.65% | 0.00% |
TLN | -6.03% | $12.18B | +104.46% | 0.00% |
CNK | -5.91% | $3.43B | +38.45% | 0.53% |
CABO | -5.84% | $746.86M | -60.59% | 6.76% |
SANM | -5.77% | $5.58B | +48.53% | 0.00% |
WRAP | -5.27% | $75.87M | -15.25% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UUP | -26.67% | $196.45M | 0.77% |
USDU | -25.38% | $129.80M | 0.5% |
TAIL | -16.74% | $94.86M | 0.59% |
VIXY | -15.82% | $184.73M | 0.85% |
AGZD | -14.65% | $98.56M | 0.23% |
CLIP | -14.41% | $1.55B | 0.07% |
UGA | -10.04% | $76.33M | 0.97% |
USO | -7.23% | $1.06B | 0.6% |
BNO | -6.94% | $110.71M | 1% |
USL | -6.93% | $43.93M | 0.85% |
CTA | -6.33% | $1.08B | 0.76% |
OILK | -6.31% | $74.12M | 0.69% |
FTSD | -6.16% | $233.11M | 0.25% |
TPMN | -5.63% | $31.06M | 0.65% |
TBLL | -5.62% | $2.12B | 0.08% |
FMF | -4.65% | $163.23M | 0.95% |
IVOL | -4.63% | $342.69M | 1.02% |
DBE | -4.57% | $54.61M | 0.77% |
DBO | -4.31% | $233.09M | 0.77% |
CANE | -4.09% | $11.14M | 0.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 59.88% | $584.35M | 0.36% |
IXJ | 54.43% | $3.75B | 0.41% |
HDEF | 53.49% | $2.03B | 0.09% |
SCHY | 53.12% | $1.19B | 0.08% |
GCOW | 52.36% | $2.35B | 0.6% |
EFAV | 51.62% | $5.46B | 0.2% |
EWL | 51.25% | $1.33B | 0.5% |
EWQ | 49.47% | $432.30M | 0.5% |
RSPH | 48.91% | $721.17M | 0.4% |
XLV | 48.64% | $34.17B | 0.09% |
IYH | 48.62% | $2.72B | 0.39% |
FICS | 48.62% | $223.13M | 0.7% |
BBH | 48.45% | $339.54M | 0.35% |
IDLV | 48.43% | $399.11M | 0.25% |
IEV | 47.97% | $2.30B | 0.61% |
FHLC | 47.83% | $2.43B | 0.084% |
IBB | 47.79% | $5.37B | 0.45% |
BBEU | 47.72% | $4.59B | 0.09% |
VHT | 47.68% | $15.34B | 0.09% |
PID | 47.61% | $854.03M | 0.53% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CLSE | -0.42% | $185.65M | 1.44% |
COMT | 0.44% | $617.76M | 0.48% |
TFLO | -0.87% | $6.74B | 0.15% |
STOT | 0.90% | $252.82M | 0.45% |
BTAL | 1.19% | $315.93M | 1.43% |
TESL | 1.26% | $29.89M | 1.2% |
KCCA | -1.33% | $108.37M | 0.87% |
CONY | 1.36% | $1.38B | 1.22% |
GSG | 1.79% | $1.02B | 0.75% |
DBC | 1.82% | $1.27B | 0.87% |
BOXX | 1.92% | $6.93B | 0.19% |
DBMF | 1.96% | $1.17B | 0.85% |
BILZ | -2.20% | $851.85M | 0.14% |
PDBC | 2.50% | $4.52B | 0.59% |
USFR | -2.57% | $18.61B | 0.15% |
BKCH | 3.31% | $188.81M | 0.5% |
SHYM | -3.45% | $355.86M | 0.35% |
GBIL | 3.48% | $6.36B | 0.12% |
BIL | -3.60% | $41.93B | 0.1356% |
BITQ | 3.76% | $248.67M | 0.85% |
Current Value
$48.641 Year Return
Current Value
$48.641 Year Return